Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$1B |
| 2 |
Merck
MRK
|
+$986M |
| 3 |
Abbott
ABT
|
+$969M |
| 4 |
NVIDIA
NVDA
|
+$967M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$814M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.46B |
| 2 |
Morgan Stanley
MS
|
+$910M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$909M |
| 4 |
Coca-Cola
KO
|
+$745M |
| 5 |
Arista Networks
ANET
|
+$692M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.51% |
| 2 | Technology | 19.42% |
| 3 | Financials | 12.78% |
| 4 | Industrials | 10.08% |
| 5 | Consumer Discretionary | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACLX
1426
DELISTED
Arcellx
ACLX
| $1.78M | ﹤0.01% |
56,202
-56,261
| -50% | -$2.15M |
|
1427
Primerica
PRI
$9.95B
| $1.76M | ﹤0.01% |
+8,919
| New | +$1.64M |
|
1428
Afya
AFYA
$1.28B
| $1.76M | ﹤0.01% |
125,293
-29,707
| -19% | -$364K |
|
1429
Ameriprise Financial
AMP
$48.9B
| $1.75M | ﹤0.01% |
5,277
-5,965
| -53% | -$1.83M |
|
1430
Five Star Bancorp
FSBC
$1.14B
| $1.74M | ﹤0.01% |
77,855
-32,939
| -30% | -$669K |
|
1431
Idexx Laboratories
IDXX
$46.2B
| $1.72M | ﹤0.01% |
3,419
-10,611
| -76% | -$5.08M |
|
1432
Hertz
HTZ
$480M
| $1.71M | ﹤0.01% |
93,183
-27,524
| -23% | -$451K |
|
|
MRNS
1433
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $1.7M | ﹤0.01% |
+156,978
| New | +$1.34M |
|
1434
Photronics
PLAB
$1.93B
| $1.69M | ﹤0.01% |
65,720
-4,061
| -6% | -$75.3K |
|
1435
Universal Health Services
UHS
$10.1B
| $1.67M | ﹤0.01% |
10,554
+4,802
| +83% | +$670K |
|
1436
Colony Bankcorp
CBAN
$474M
| $1.65M | ﹤0.01% |
175,678
-78,339
| -31% | -$744K |
|
|
CWBC
1437
DELISTED
Community West BanCshares
CWBC
| $1.65M | ﹤0.01% |
134,585
-45,099
| -25% | -$532K |
|
1438
Cigna
CI
$72B
| $1.63M | ﹤0.01% |
5,824
+197
| +4% | +$51.3K |
|
1439
iShares MSCI Emerging Markets ETF
EEM
$29.7B
| $1.63M | ﹤0.01% |
41,303
-10,420
| -20% | -$410K |
|
1440
Starwood Property Trust
STWD
$6.02B
| $1.59M | ﹤0.01% |
82,117
-7,363
| -8% | -$131K |
|
1441
Investar Holding Corp
ISTR
$422M
| $1.59M | ﹤0.01% |
131,308
-61,859
| -32% | -$759K |
|
1442
Black Hills Corp
BKH
$5.5B
| $1.59M | ﹤0.01% |
26,325
| – | – |
|
1443
Farmers National Banc Corp
FMNB
$952M
| $1.58M | ﹤0.01% |
127,922
-53,956
| -30% | -$644K |
|
1444
Wheaton Precious Metals
WPM
$52.6B
| $1.56M | ﹤0.01% |
36,051
+21,092
| +141% | +$1M |
|
1445
NCR Voyix
VYX
$1.21B
| $1.56M | ﹤0.01% |
100,951
+44,646
| +79% | +$644K |
|
1446
Dycom Industries
DY
$12.6B
| $1.55M | ﹤0.01% |
13,659
-240,771
| -95% | -$23.8M |
|
1447
Kforce
KFRC
$1.03B
| $1.55M | ﹤0.01% |
+24,768
| New | +$1.49M |
|
1448
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24B
| $1.54M | ﹤0.01% |
11,112
| – | – |
|
1449
Campbell Soup
CPB
$6.81B
| $1.53M | ﹤0.01% |
33,404
-94,075
| -74% | -$4.85M |
|
1450
West Pharmaceutical
WST
$24.5B
| $1.51M | ﹤0.01% |
3,946
+429
| +12% | +$153K |
|
Similar funds
Wellington Management Group's Q2 2023 Portfolio in Review
As of Q2 2023, Wellington Management Group held 2,099 positions worth $527B, up 4.5% from $505B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Wellington Management Group's Q2 2023 filing shows 119 new, 718 increased, 815 reduced and 304 closed positions. Its largest new stake was Kenvue: 10,602,707 shares worth $280M. The largest sale was Eli Lilly, an estimated $2.46B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Technology and Financials.
- Wellington Management Group's largest Q2 2023 buy was Kenvue: 10,602,707 shares worth $280M.
- Wellington Management Group added most to Gilead Sciences in Q2 2023, an estimated $1B increase.
- Wellington Management Group's biggest Q2 2023 reduction was Eli Lilly, cutting an estimated $2.46B.
- Wellington Management Group fully exited Syneos Health, Inc. Class A Common Stock in Q2 2023, selling an estimated $267M.
- Wellington Management Group's ten largest holdings make up 20% of its $527B portfolio in Q2 2023.
- Wellington Management Group opened 119 new positions and closed 304 in Q2 2023.
- Wellington Management Group's portfolio value rose 4.5% quarter-over-quarter to $527B.
Based on Wellington Management Group's 13F filing for Q2 2023, filed 14 Aug 2023.